Back

Availability and prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018-2022

2024-01-07 addiction medicine Title + abstract only
View on medRxiv
Show abstract

Background and aimsExtended release buprenorphine injection (INJ-BUP) has been available in the United States since 2018. INJ-BUP has the potential to positively impact OUD treatment outcomes by providing additional treatment options and patient choice. We aimed to describe the availability and prescribing of INJ-BUP for Medicaid beneficiaries since its availability, nationwide and by state. MethodsTo assess availability, we measured the number of substance use disorder (SUD) facilities that of...

Predicted journal destinations